o2h ChaiTime - Korea 2026

​Join us for the first international edition of o2h ChaiTime, hosted at Aston Hall, British Embassy Seoul on Friday, 2 October 2026.

​o2h ChaiTime is an invite-only, discussion-led life sciences forum bringing together Korean and international biotech investors, family offices, pharma leaders, founders and strategic partners for focused conversations around the opportunities shaping the sector.

​The afternoon will bring together perspectives from across the Korean and UK life sciences ecosystems, alongside a showcase of three UK biotech companies at important commercial, clinical and partnering stages.

​A quick look at the afternoon

• ​14:00–14:15 | Arrival & Networking

• ​14:15–14:25 | Welcome Remarks

• ​14:25–14:40 | Keynote Address: Build the Value Before the Listing: Partnering at the Target, from Cambridge to Seoul
  Namshik Han, Co-Founder & CTO, CardiaTec

• ​14:40–15:05 | Exclusive Fireside Chat
  Sunil Shah, CEO, o2h Ventures, in conversation with Daekyeong Bae, Senior VP, Korea Omega Investment Corp

• ​15:05–15:55 | UK Biotech Company Showcase

  • ​15:05–15:20 | Atelerix | Alastair Carrington, CEO
    10-minute presentation + 5-minute Q&A

  • ​15:20–15:35 | Spirea | Adam Collier, CBO
    10-minute presentation + 5-minute Q&A

  • ​15:35–15:50 | Heartfelt | Joe Nelson, COO
    10-minute presentation + 5-minute Q&A

• ​15:50–16:00 | Closing Remarks

• ​16:00–17:00 | Networking Drinks Reception

​The afternoon will bring together Korean, UK and international investors, founders, pharma and biotech leaders and strategic partners, with the drinks reception providing an opportunity to continue conversations and explore connections across the two ecosystems.

​Attendance

​This is an invite-only event with limited capacity.

​To maintain a relevant mix of investors, pharma leaders, biotech companies and strategic partners, all registrations will be reviewed by the host before attendance is confirmed.